Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid Malignancies

This review discusses diagnostic, prognostic, and treatment implications of mutation profiling for MPNs, in addition to highlighting the newly discovered clonal hematopoiesis of indeterminate potential (CHIP) mutation.

 Oncology (Williston Park)

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.